From AI-driven R&D to digital supply chains and next-generation biomanufacturing, this collection covers the full breadth of where pharma and biotech innovation stands in mid-2026.
Inside:
- Enamine at 35: from Kyiv startup to top-20 CRO
- Digital twins for supply chain planning — what good implementation looks like
- How Roche, Bayer, Merck and Boehringer Ingelheim are actually using digitalization across R&D
- Smart experimentation: why most R&D teams run 2–5x more experiments than they need to
Read issue
Download PDF
